Aging-related arterial-cardiac interaction in Japanese men

Yoshiaki Maruyama1

  • 1Department of Health Promotion, Saitama Medical Center, Saitama Medical University, 1981 Kamoda-Tsujidomachi, Kawagoe 350-8550, Japan. ymaru@saitama-med.ac.jp

Heart and Vessels
|January 29, 2010
PubMed

Insights

Vascular and cardiac aging accelerates with age, showing strong arterial-cardiac interactions. Key indicators like pulse wave velocity increase significantly after 55, reflecting atherosclerosis progression.

Area of Science:

  • Cardiovascular Research
  • Gerontology
  • Biomedical Engineering

Background:

  • Vascular and cardiac aging are significant concerns in Japan.
  • Arterial-cardiac interaction is crucial but poorly understood with age.
  • Pulse wave velocity (PWV) is a key indicator of atherosclerosis.

Purpose of the Study:

  • To investigate age-related changes in arterial-cardiac interaction.
  • To analyze the relationship between aging, atherosclerosis (PWV), and cardiac parameters.
  • To identify early indicators of vascular and cardiac aging.

Main Methods:

  • Studied 595 adult men without cardiovascular disease history.
  • Correlated age with PWV, cardiac structure, cardiac function, and blood pressure.
  • Analyzed parameters across five age groups.

Main Results:

  • PWV strongly correlated with age (r=0.461) and increased significantly post-55.
  • Left atrial dimension, relative wall thickness, systolic blood pressure, and pulse pressure increased with age and correlated with PWV.
  • Left ventricular volume decreased with age.
  • Aortic diameter and E/A ratio showed age-related changes earlier than PWV.
  • Diastolic blood pressure varied with age, increasing early and decreasing late.

Conclusions:

  • Age-related atherosclerotic arterial-cardiac interaction is confirmed.
  • Aortic diameter, E/A ratio, and diastolic blood pressure exhibit early age-related changes independent of atherosclerosis.
  • Understanding these distinct aging patterns is vital for cardiovascular health assessment.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...